Adjuvant chemotherapy in high-risk malignant melanoma
β Scribed by Dr. Constantine P. Karakousis; Lawrence J. Emrich
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 363 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Fortyβone patients were treated with BCG immunotherapy following block dissection of lymph nodes involved with malignant melanoma. A control group of similar patients who received no immunotherapy was drawn from a population consisting of all patients with malignant melanoma diagnosed i
## Abstract ## BACKGROUND It has been shown that induction highβdose interferon Ξ±β2b (IFNβΞ±β2b) followed by maintenance therapy improves recurrenceβfree survival in adults with highβrisk, resected melanoma. In this study, the feasibility and toxicity of this regimen were evaluated in newly diagnos